Ghost Tree Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.76M Sell
2024
Q2
$5.88M Buy
2024
Q1
$3.79M Buy
2023
Q1
Sell
2022
Q4
$360K Sell
2022
Q3
$526K Buy
2022
Q2
$467K Buy
2022
Q1
$1.58M Buy
2016
Q4
Sell
2016
Q3
$321K Hold
2016
Q2
$243K Buy